The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Custom Recombinant Antibody Production Service Market Research Report 2025

Global Custom Recombinant Antibody Production Service Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1745175

No of Pages : 103

Ask Your Query

Synopsis
Global Custom Recombinant Antibody Production Service market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Custom Recombinant Antibody Production Service market research.

Key companies engaged in the Custom Recombinant Antibody Production Service industry include evitria, ProSci, GenScript, RayBiotech, Cygnus Technologies, Cayman Chemical, Boster Bio, Bon Opus Biosciences and Biomatik, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Custom Recombinant Antibody Production Service were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Custom Recombinant Antibody Production Service market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Custom Recombinant Antibody Production Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • evitria
  • ProSci
  • GenScript
  • RayBiotech
  • Cygnus Technologies
  • Cayman Chemical
  • Boster Bio
  • Bon Opus Biosciences
  • Biomatik
  • Abcam
  • Bio-Rad
  • Creative Biolabs
  • ProteoGenix
  • Sino Biological
  • Absolute Antibody
  • ProMab Biotechnologies
  • ACROBiosystems
  • Cusabio Technology
  • Covance

Segment by Type

  • Monoclonal Antibody (mAb) Production
  • Polyclonal Antibody (pAb) Production

Segment by Application

  • Pharmaceutics
  • Scientific Research
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil,Turkey, GCC Countries)

The Custom Recombinant Antibody Production Service report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Custom Recombinant Antibody Production Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibody (mAb) Production
1.2.3 Polyclonal Antibody (pAb) Production
1.3 Market by Application
1.3.1 Global Custom Recombinant Antibody Production Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutics
1.3.3 Scientific Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Custom Recombinant Antibody Production Service Market Perspective (2018-2029)
2.2 Custom Recombinant Antibody Production Service Growth Trends by Region
2.2.1 Global Custom Recombinant Antibody Production Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Custom Recombinant Antibody Production Service Historic Market Size by Region (2018-2023)
2.2.3 Custom Recombinant Antibody Production Service Forecasted Market Size by Region (2024-2029)
2.3 Custom Recombinant Antibody Production Service Market Dynamics
2.3.1 Custom Recombinant Antibody Production Service Industry Trends
2.3.2 Custom Recombinant Antibody Production Service Market Drivers
2.3.3 Custom Recombinant Antibody Production Service Market Challenges
2.3.4 Custom Recombinant Antibody Production Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Custom Recombinant Antibody Production Service Players by Revenue
3.1.1 Global Top Custom Recombinant Antibody Production Service Players by Revenue (2018-2023)
3.1.2 Global Custom Recombinant Antibody Production Service Revenue Market Share by Players (2018-2023)
3.2 Global Custom Recombinant Antibody Production Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Custom Recombinant Antibody Production Service Revenue
3.4 Global Custom Recombinant Antibody Production Service Market Concentration Ratio
3.4.1 Global Custom Recombinant Antibody Production Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Custom Recombinant Antibody Production Service Revenue in 2022
3.5 Custom Recombinant Antibody Production Service Key Players Head office and Area Served
3.6 Key Players Custom Recombinant Antibody Production Service Product Solution and Service
3.7 Date of Enter into Custom Recombinant Antibody Production Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Custom Recombinant Antibody Production Service Breakdown Data by Type
4.1 Global Custom Recombinant Antibody Production Service Historic Market Size by Type (2018-2023)
4.2 Global Custom Recombinant Antibody Production Service Forecasted Market Size by Type (2024-2029)
5 Custom Recombinant Antibody Production Service Breakdown Data by Application
5.1 Global Custom Recombinant Antibody Production Service Historic Market Size by Application (2018-2023)
5.2 Global Custom Recombinant Antibody Production Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Custom Recombinant Antibody Production Service Market Size (2018-2029)
6.2 North America Custom Recombinant Antibody Production Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Custom Recombinant Antibody Production Service Market Size by Country (2018-2023)
6.4 North America Custom Recombinant Antibody Production Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Custom Recombinant Antibody Production Service Market Size (2018-2029)
7.2 Europe Custom Recombinant Antibody Production Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Custom Recombinant Antibody Production Service Market Size by Country (2018-2023)
7.4 Europe Custom Recombinant Antibody Production Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Custom Recombinant Antibody Production Service Market Size (2018-2029)
8.2 Asia-Pacific Custom Recombinant Antibody Production Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Custom Recombinant Antibody Production Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Custom Recombinant Antibody Production Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Custom Recombinant Antibody Production Service Market Size (2018-2029)
9.2 Latin America Custom Recombinant Antibody Production Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Custom Recombinant Antibody Production Service Market Size by Country (2018-2023)
9.4 Latin America Custom Recombinant Antibody Production Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Custom Recombinant Antibody Production Service Market Size (2018-2029)
10.2 Middle East & Africa Custom Recombinant Antibody Production Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 evitria
11.1.1 evitria Company Detail
11.1.2 evitria Business Overview
11.1.3 evitria Custom Recombinant Antibody Production Service Introduction
11.1.4 evitria Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.1.5 evitria Recent Development
11.2 ProSci
11.2.1 ProSci Company Detail
11.2.2 ProSci Business Overview
11.2.3 ProSci Custom Recombinant Antibody Production Service Introduction
11.2.4 ProSci Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.2.5 ProSci Recent Development
11.3 GenScript
11.3.1 GenScript Company Detail
11.3.2 GenScript Business Overview
11.3.3 GenScript Custom Recombinant Antibody Production Service Introduction
11.3.4 GenScript Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.3.5 GenScript Recent Development
11.4 RayBiotech
11.4.1 RayBiotech Company Detail
11.4.2 RayBiotech Business Overview
11.4.3 RayBiotech Custom Recombinant Antibody Production Service Introduction
11.4.4 RayBiotech Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.4.5 RayBiotech Recent Development
11.5 Cygnus Technologies
11.5.1 Cygnus Technologies Company Detail
11.5.2 Cygnus Technologies Business Overview
11.5.3 Cygnus Technologies Custom Recombinant Antibody Production Service Introduction
11.5.4 Cygnus Technologies Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.5.5 Cygnus Technologies Recent Development
11.6 Cayman Chemical
11.6.1 Cayman Chemical Company Detail
11.6.2 Cayman Chemical Business Overview
11.6.3 Cayman Chemical Custom Recombinant Antibody Production Service Introduction
11.6.4 Cayman Chemical Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.6.5 Cayman Chemical Recent Development
11.7 Boster Bio
11.7.1 Boster Bio Company Detail
11.7.2 Boster Bio Business Overview
11.7.3 Boster Bio Custom Recombinant Antibody Production Service Introduction
11.7.4 Boster Bio Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.7.5 Boster Bio Recent Development
11.8 Bon Opus Biosciences
11.8.1 Bon Opus Biosciences Company Detail
11.8.2 Bon Opus Biosciences Business Overview
11.8.3 Bon Opus Biosciences Custom Recombinant Antibody Production Service Introduction
11.8.4 Bon Opus Biosciences Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.8.5 Bon Opus Biosciences Recent Development
11.9 Biomatik
11.9.1 Biomatik Company Detail
11.9.2 Biomatik Business Overview
11.9.3 Biomatik Custom Recombinant Antibody Production Service Introduction
11.9.4 Biomatik Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.9.5 Biomatik Recent Development
11.10 Abcam
11.10.1 Abcam Company Detail
11.10.2 Abcam Business Overview
11.10.3 Abcam Custom Recombinant Antibody Production Service Introduction
11.10.4 Abcam Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.10.5 Abcam Recent Development
11.11 Bio-Rad
11.11.1 Bio-Rad Company Detail
11.11.2 Bio-Rad Business Overview
11.11.3 Bio-Rad Custom Recombinant Antibody Production Service Introduction
11.11.4 Bio-Rad Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.11.5 Bio-Rad Recent Development
11.12 Creative Biolabs
11.12.1 Creative Biolabs Company Detail
11.12.2 Creative Biolabs Business Overview
11.12.3 Creative Biolabs Custom Recombinant Antibody Production Service Introduction
11.12.4 Creative Biolabs Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.12.5 Creative Biolabs Recent Development
11.13 ProteoGenix
11.13.1 ProteoGenix Company Detail
11.13.2 ProteoGenix Business Overview
11.13.3 ProteoGenix Custom Recombinant Antibody Production Service Introduction
11.13.4 ProteoGenix Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.13.5 ProteoGenix Recent Development
11.14 Sino Biological
11.14.1 Sino Biological Company Detail
11.14.2 Sino Biological Business Overview
11.14.3 Sino Biological Custom Recombinant Antibody Production Service Introduction
11.14.4 Sino Biological Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.14.5 Sino Biological Recent Development
11.15 Absolute Antibody
11.15.1 Absolute Antibody Company Detail
11.15.2 Absolute Antibody Business Overview
11.15.3 Absolute Antibody Custom Recombinant Antibody Production Service Introduction
11.15.4 Absolute Antibody Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.15.5 Absolute Antibody Recent Development
11.16 ProMab Biotechnologies
11.16.1 ProMab Biotechnologies Company Detail
11.16.2 ProMab Biotechnologies Business Overview
11.16.3 ProMab Biotechnologies Custom Recombinant Antibody Production Service Introduction
11.16.4 ProMab Biotechnologies Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.16.5 ProMab Biotechnologies Recent Development
11.17 ACROBiosystems
11.17.1 ACROBiosystems Company Detail
11.17.2 ACROBiosystems Business Overview
11.17.3 ACROBiosystems Custom Recombinant Antibody Production Service Introduction
11.17.4 ACROBiosystems Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.17.5 ACROBiosystems Recent Development
11.18 Cusabio Technology
11.18.1 Cusabio Technology Company Detail
11.18.2 Cusabio Technology Business Overview
11.18.3 Cusabio Technology Custom Recombinant Antibody Production Service Introduction
11.18.4 Cusabio Technology Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.18.5 Cusabio Technology Recent Development
11.19 Covance
11.19.1 Covance Company Detail
11.19.2 Covance Business Overview
11.19.3 Covance Custom Recombinant Antibody Production Service Introduction
11.19.4 Covance Revenue in Custom Recombinant Antibody Production Service Business (2018-2023)
11.19.5 Covance Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock